Stocks
Deciphera Pharmaceuticals (DCPH) R&D/CAPEX US GAAP (year values) |
|||||||||
| 2019 | 2020 | 2021 | 2022 | 2023 | LTM ? | CAGR 5 years ? | |||
| R&D/CAPEX, % | 3 194% | 3 743% | 4 306% | 22 333% | 30 093% | 41 976% | |||
| Changes by years, y/y, % | -4 174pp | +549pp | +563pp | +18 028pp | +7 760pp | +32.5% | |||
Deciphera Pharmaceuticals. R&D/CAPEX, %
Deciphera Pharmaceuticals. R&D/CAPEX, changes, pp
Deciphera Pharmaceuticals (DCPH) R&D/CAPEX US GAAP (quarter values) |
||||||||
| 2023Q1 | 2023Q2 | 2023Q3 | 2023Q4 | 2024Q1 | LTM ? | |||
| R&D/CAPEX, % | 15 213% | 19 896% | 100 747% | 93 014% | 39 304% | 41 976% | ||
| Changes by years, y/y, % | +4 266pp | +92 460pp | +75 079pp | +24 092pp | ||||
| Changes by quarters, q/q, % | -2 723pp | +4 684pp | +80 851pp | -7 732pp | -53 710pp | |||
